Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial. (Q40245246)

From Wikidata

Jump to navigation Jump to search

scientific article published on 22 September 2016

Language	Label	Description	Also known as
English	Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.	scientific article published on 22 September 2016

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Henry L Y Chan

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Scott Fung

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Wan-Long Chuang

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Chi-Yi Chen

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Hyung Joon Kim

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Aric Josun Hui

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Harry L A Janssen

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Abhijit Chowdhury

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Tak Yin Owen Tsang

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Rajiv Mehta

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Edward Gane

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

John F Flaherty

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Benedetta Massetto

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Anuj Gaggar

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Kathryn M Kitrinos

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Lanjia Lin

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

G Mani Subramanian

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

John G McHutchison

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Young-Suk Lim

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Subrat K Acharya

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Kosh Agarwal

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

GS-US-320-0110 Investigators

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

publication date

22 September 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

The lancet. Gastroenterology & hepatology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

185-195

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic hepatitis B infection.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

AASLD guidelines for treatment of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism for effective lymphoid cell and tissue loading following oral administration of nucleotide prodrug GS-7340.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Implications of efficient hepatic delivery by tenofovir alafenamide (GS-7340) for hepatitis B virus therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The safety and efficacy of tenofovir DF in combination with lamivudine and efavirenz through 6 years in antiretroviral-naïve HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of bone mineral density in tenofovir-treated patients with chronic hepatitis B: can the fracture risk assessment tool identify those at greatest risk?

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Association Between Chronic Hepatitis B Virus Infection and Risk of Osteoporosis: A Nationwide Population-Based Study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir-induced Fanconi syndrome in chronic hepatitis B monoinfected patients that reverted after tenofovir withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of nucleoside and nucleotide analogues on renal function in patients with chronic hepatitis B virus monoinfection.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of retinol-binding protein and β2-microglobulin determination in urine for the early detection of tubular proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930024-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2468-1253(16)30024-3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404091%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40245246&oldid=1590450566"